Serum Detection of Nonadherence to Adjuvant Tamoxifen and Breast Cancer Recurrence Risk

PURPOSE: Nonadherence to long-term treatments is often under-recognized by physicians and there is no gold standard for its assessment. In breast cancer, nonadherence to tamoxifen therapy after surgery constitutes a major obstacle to optimal outcomes. We sought to evaluate the rate of biochemical no...

Descripción completa

Detalles Bibliográficos
Autores principales: Pistilli, Barbara, Paci, Angelo, Ferreira, Arlindo R., Di Meglio, Antonio, Poinsignon, Vianney, Bardet, Aurelie, Menvielle, Gwenn, Dumas, Agnes, Pinto, Sandrine, Dauchy, Sarah, Fasse, Leonor, Cottu, Paul H., Lerebours, Florence, Coutant, Charles, Lesur, Anne, Tredan, Olivier, Soulie, Patrick, Vanlemmens, Laurence, Jouannaud, Christelle, Levy, Christelle, Everhard, Sibille, Arveux, Patrick, Martin, Anne Laure, Dima, Alexandra, Lin, Nancy U., Partridge, Ann H., Delaloge, Suzette, Michiels, Stefan, André, Fabrice, Vaz-Luis, Ines
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2020
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430219/
https://www.ncbi.nlm.nih.gov/pubmed/32568632
http://dx.doi.org/10.1200/JCO.19.01758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430219/
https://www.ncbi.nlm.nih.gov/pubmed/32568632
http://dx.doi.org/10.1200/JCO.19.01758

Ejemplares similares